热线电话: 021-34661275
产品分类/PRODUCT CLASSIFICATION

上海细胞库

人源细胞系| 稳转细胞系| 基因敲除株| 基因点突变细胞株| 基因过表达细胞株| 重组细胞系| 猪的细胞系| 马细胞系| 兔的细胞系| 犬的细胞系| 山羊的细胞系| 鱼的细胞系| 猴的细胞系| 仓鼠的细胞系| 狗的细胞系| 牛的细胞| 大鼠细胞系| 小鼠细胞系| 其他细胞系|

原代细胞

原代细胞| 永生化细胞|

细胞培养

血清| 无血清冻存| 细胞培养试剂盒| 普通培养基| 完全培养基| 细胞污染预防| 细胞污染清除| 细胞培养辅助试剂|

细胞服务

STR鉴定服务| ATCC代购服务|

酶联试剂盒

人ELISA试剂盒| 大鼠ELISA试剂盒| 小鼠ELISA试剂盒| 兔ELISA试剂盒| 猪ELISA试剂盒| 鱼ELISA试剂盒| 牛ELISA试剂盒| 犬ELISA试剂盒| 鸭ELISA试剂盒| 豚鼠ELISA试剂盒| 鸡ELISA试剂盒| 绵羊ELISA试剂盒| 山羊ELISA试剂盒| 仓鼠ELISA试剂盒| 植物ELISA试剂盒| 药残留类试剂盒| 其他ELISA试剂盒|

生化试剂盒

生化试剂盒| 微量法检测盒| 分光法检测盒| 胶体金检测盒|

PCR试剂盒

荧光探针PCR试剂盒| 染料荧光PCR试剂盒| 核酸扩增/纯化| 普通PCR检测试剂盒| 质粒菌种感受态|

抗体蛋白

蛋白多肽| 抗体| 免疫组化| 免疫球蛋白|

试剂耗材

标准试液| 科研试剂| 缓 冲 液| 实验耗材| 高效液相色谱对照品|

首页 > 抗体蛋白 > 抗体
PE/Cyanine7 anti-mouse/human CD45R/B220 Antibody
产品名称：
PE/Cyanine7 anti-mouse/human CD45R/B220 Antibody
产品类别：
抗体
产品编号：
103221
产品应用：
103221
[价格]
规格 价格 库存
25µg ￥ 1218 1

产品详情

Product Details

Verified Reactivity
Mouse, Human
Reported Reactivity
Cat
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Abelson murine leukemia virus-induced pre-B tumor cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE/Cyanine7 under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 ?g per 106 cells in 100 ?l volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Clone RA3-6B2 has been described to react with an epitope on the extracellular domain of the transmembrane CD45 glycoprotein which is dependent upon the expression of exon A and specific carbohydrate residues. Additional reported applications (for the relevant formats) include: immunoprecipitation1, in vitro and in vivo modulation of B cell responses2-4, immunohistochemistry of acetone-fixed frozen sections and formalin-fixed paraffin-embedded sections5,6, and spatial biology (IBEX)14,15.

Additional Product Notes
BioLegend is in the process of converting the name PE/Cy7 to PE/Cyanine7. The dye molecule remains the same, so you should expect the same quality and performance from our PE/Cyanine7 products. Please contact Technical Service if you have any questions.
Application References

(PubMed link indicates BioLegend citation)
  1. Coffman RL. 1982. Immunol. Rev. 69:5. (IP)
  2. George A, et al. 1994. J. Immunol. 152:1014. (Activ)
  3. Asensi V, et al. 1989. Immunology 68:204. (Activ)
  4. Domiati-Saad R, et al. 1993. J. Immunol. 151:5936. (Activ)
  5. Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC)
  6. Monteith CE, et al. 1996. Can. J. Vet. Res. 60:193. (IHC)
  7. Shih FF, et al. 2006. J. Immunol. 176:3438. (FC)
  8. Chang C L-T, et al. 2007. J. Immunol. 178:6984.
  9. Fazilleau N, et al. 2007. Nature Immunol. 8:753.
  10. Lang GL, et al. 2008. Blood 111:2158. PubMed
  11. Charles N, et al. 2010. Nat. Med. 16:701. (FC) PubMed
  12. del Rio ML, et al. 2011. Transpl. Int. 24:501. (FC) PubMed
  13. Murakami R, et al. 2013. PLoS One. 8:73270. PubMed
  14. Radtke?AJ,?et al.?2020.?Proc Natl Acad Sci U S A.?117:33455-65. (SB)?PubMed
  15. Radtke?AJ,?et al.?2022.?Nat Protoc.?17:378-401. (SB)?PubMed
Product Citations
  1. Tran NT, et al. 2019. Cell Rep. 28:3510. PubMed
  2. Nagamachi A, et al. 2021. J Clin Invest. 131:. PubMed
  3. Ouchida R, et al. 2012. Proc Natl Acad Sci U S A. 109:e2699. PubMed
  4. A?t-Azzouzene D, et al. 2010. J Immunol. 185:1015. PubMed
  5. Viny AD, et al. 2019. Cell Stem Cell. 25:682. PubMed
  6. Sakamoto A, et al. 2017. Int Immunol. . 10.1093/intimm/dxx054. PubMed
  7. Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed
  8. Sch?nberger K, et al. 2022. Cell Stem Cell. 29:131. PubMed
  9. Symeonidou V, et al. 2021. Cell Rep. 37:109900. PubMed
  10. Farsakoglu Y et al. 2019. Cell reports. 26(9):2307-2315 . PubMed
  11. Ersching J et al. 2017. Immunity. 46(6):1045-1058 . PubMed
  12. Manion KP, et al. 2020. PLoS One. 15:e0236664. PubMed
  13. Gutiérrez-Gutiérrez ?, et al. 2021. EMBO Rep. 22:e52905. PubMed
  14. Paubelle E, et al. 2020. Cell Reports. 30(3):739-754.e4.. PubMed
  15. Li Y, et al. 2020. Cell Rep. 30:1753. PubMed
  16. Castellanos CA, et al. 2021. Sci Immunol. 6:eabh0707. PubMed
  17. Mathew NR, et al. 2021. Cell Reports. 35(12):109286. PubMed
  18. Pérez‐Mazliah D et al. 2017. EBioMedicine. 24:216-230 . PubMed
  19. Fukushima T, et al. 2019. Cell Rep. 29:4144. PubMed
  20. Suzuki M, et al. 2021. Sci Adv. 7:. PubMed
  21. Ohyagi M, et al. 2021. Nat Commun. 12:7344. PubMed
  22. Majumder P, et al. 2021. J Immunol. 206:2221. PubMed
  23. Heizmann B, et al. 2013. J Exp Med. 210:2823. PubMed
  24. Sharma PK, et al. 2018. Cancer Gene Ther. 25:27. PubMed
  25. Silva M, et al. 2021. Sci Immunol. 6:eabf1152. PubMed
  26. Li Y, et al. 2022. Clin Transl Immunology. 11:e1362. PubMed
  27. Lee RD, et al. 2021. Nat Commun. 12:6843. PubMed
  28. Shan M et al. 2018. Immunity. 49(4):709-724 . PubMed
  29. He W et al. 2018. Immunity. 49(6):1175-1190 . PubMed
  30. Terashima Y, et al. 2020. Nat Commun. 11:609. PubMed
  31. Sandborn WJ, et al. 2021. Gastroenterology. 161:1853. PubMed
  32. Li X, et al. 2020. Mol Ther. 28:2430. PubMed
  33. Burrack K, et al. 2015. PLoS Pathog. 11: e1005191. PubMed
  34. Stacey M, et al. 2011. J Immunol. 187:2944. PubMed
  35. Fallet B, et al. 2020. Cell Rep. 30:1013. PubMed
  36. Liu D et al. 2019. Immunity. 51(1):64-76 . PubMed
  37. Kotaki R, et al. 2020. Sci Rep. 10:13554. PubMed
  38. Kobayashi M, et al. 2020. Bio Protoc. 10:e3601. PubMed
  39. Fennell LM, et al. 2020. EMBO J. 39:e103303. PubMed
  40. Volberding PJ, et al. 2021. Cell Reports. 35(8):109160. PubMed
  41. Burrack K, et al. 2015. J Immunol. 194:678. PubMed
  42. Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed
  43. Albarrán-Juárez J, et al. 2016. Atherosclerosis. 251:445-53. PubMed
  44. Wanner-Seleznik GM, et al. 2020. Immunohorizons. 0.644444444. PubMed
  45. Trefzer A, et al. 2021. Cell Reports. 34(6):108748. PubMed
  46. Zhu H, et al. 2019. Nat Commun. 10:1084. PubMed
  47. Tran NT, et al. 2020. STAR Protocols. 1(1):100028. PubMed
  48. Yi W, et al. 2021. Cell Reports. 34(13):108922. PubMed
  49. Crouse B, et al. 2020. NPJ Vaccines. 0.277083333. PubMed
  50. Rozanski C, et al. 2015. J Immunol. 194:4717. PubMed
  51. Chen Z, et al. 2019. J Exp Med. 216:152. PubMed
  52. Timilshina M, et al. 2017. PLoS One. 10.1371/journal.pone.0168942. PubMed
  53. Di Mitri D, et al. 2019. Cell Rep. 28:2156. PubMed
  54. Zeng Q, et al. 2022. iScience. 25:105151. PubMed
  55. Chen RJ, et al. 2022. iScience. 25:105595. PubMed
  56. Chen R, et al. 2021. Cell Reports. 34(7):108751. PubMed
  57. Alexandre YO, et al. 2020. Cell Reports. 33(13):108567. PubMed
  58. Tozuka M, et al. 2016. J Dermatol Sci. 82: 38-45. PubMed
  59. Lamoureux J, et al. 2007. J Exp Med. 204:2853. PubMed
  60. Xueyang Yu et al. 2017. Immunity. 47(5):903-912 . PubMed
  61. Kiyohara H, et al. 2018. Cell Mol Gastroenterol Hepatol. 7:135. PubMed
  62. Zhang CR, et al. 2022. Blood Cancer Discov. 3:220. PubMed
  63. Wang W, et al. 2021. J Am Heart Assoc. 10:e019142. PubMed
  64. Ha TC, et al. 2020. Hum Gene Ther. 32:458. PubMed
  65. Richardson ET, et al. 2015. PLoS One. 10: 1371. PubMed
  66. Miyauchi K, et al. 2016. Nat Immunol. 17:1447-1458. PubMed
  67. Kobia FM, et al. 2020. PLoS Biol. 18:e3000850. PubMed
  68. Haniuda K, et al. 2020. Cell Rep. 33:108333. PubMed
  69. Celik H, et al. 2018. Cancer Cell. 34:741. PubMed
  70. Lu X, et al. 2019. Cell Rep. 28:472. PubMed
  71. Shehata L, et al. 2019. Cell Rep. 28:3300. PubMed
  72. Sch?nberger K, et al. 2022. STAR Protoc. 3:101408. PubMed
  73. Agrawal M, et al. 2022. Blood. 140:1094. PubMed
  74. Ulrich V, et al. 2016. EMBO Mol Med. 8: 643 - 653. PubMed
  75. Valkenburg S, et al. 2016. Sci Rep. 6:22666. PubMed
  76. Xie X, et al. 2015. Sci Rep. 5: 18115. PubMed
  77. Leary N, et al. 2022. J Extracell Vesicles. 11:e12197. PubMed
  78. El-Zaatari M, et al. 2017. Gastroenterology. 10.1053/j.gastro.2017.09.002. PubMed
  79. Satoh–Takayama N, et al. 2020. Immunity. 52(4):635-649. PubMed
  80. Chao JL, et al. 2021. Cell Rep Med. 2:100399. PubMed
  81. Read BJ, et al. 2022. Cell Rep. 38:110217. PubMed
  82. Zhong C, et al. 2021. J Virol. 95:e0092521. PubMed
  83. Matsushita N, et al. 2016. Sci Rep. 6:31266. PubMed
  84. Ramanan D, et al. 2020. Cell. 181(6):1276-1290. PubMed
  85. Tomita T, et al. 2021. Nat Commun. 12:3655. PubMed
  86. Timilshina M, et al. 2020. Cell Reports. 27(10):2948-2961.e7.. PubMed
  87. Rappe JCF, et al. 2021. J Exp Med. 218:. PubMed
  88. Zhang M, et al. 2022. iScience. 25:104490. PubMed
  89. Rodrigues KA, et al. 2021. Sci Adv. 7:eabj6538. PubMed
  90. Liu A, et al. 2022. Front Cell Infect Microbiol. 12:960208. PubMed
  91. Nabekura T, et al. 2020. Immunity. 96:52. PubMed
  92. Patterson DG, et al. 2021. J Immunol. 207:1798. PubMed
  93. Wirasinha RC, et al. 2021. J Exp Med. 218: . PubMed
RRID
AB_313004 (BioLegend Cat. No. 103221) AB_313005 (BioLegend Cat. No. 103222)

Antigen Details

Structure
Protein tyrosine phosphatase (PTP) family, 180-240 kD
Distribution

B cells, T cell subset, NK cell subset

Function
Phosphatase, T and B cell activation
Ligand/Receptor
Galectin-1, CD2, CD3, CD4
Cell Type
B cells, NK cells, T cells
Biology Area
Cell Biology, Immunology, Inhibitory Molecules, Neuroscience, Neuroscience Cell Markers
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Trowbridge IS, et al. 1993. Annu. Rev. Immunol. 12:85.
3. Kishihara K, et al. 1993. Cell 74:143.
4. Pulido R, et al. 1988. J. Immunol. 140:3851.

Gene ID
19264 View all products for this Gene ID 5788 View all products for this Gene ID
UniProt
View information about CD45R on UniProt.org

联系我们

TEL：021-34661275 　点击拨打热线